SGX Google Yahoo TradingView

IX BIOPHARMA LTD. (42C) SGD 0.375   +0.00% +0.00

Portfolio Watchlist
AllFinancialBuy BackInsider Trading

IX Biopharma

2022-08-22
Financial Statements and Related Announcement::Full Yearly Results

IX Biopharma

2022-07-21
Placements::PROPOSED PLACEMENT OF 13,710,000 NEW ORDINARY SHARES - ALLOTMENT AND ISSUE OF SUBSCRIPTION SHARES

IX Biopharma

2022-07-19
Placements::PROPOSED PLACEMENT OF 13,710,000 NEW ORDINARY SHARES - RECEIPT OF LISTING AND QUOTATION NOTICE

IX Biopharma

2022-07-18
General Announcement::DRUG DEVELOPMENT UPDATES FOR WAFERMINE AND WAFESIL

IX Biopharma

2022-07-15
Change - Announcement of Cessation::Cessation of Director of Corporate Affairs & General Manager - Yee Chia Hsing

IX Biopharma

2022-07-12
Placements::PROPOSED PLACEMENT OF 13,710,000 NEW ORDINARY SHARES

IX Biopharma

2022-07-07
REPL::Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notice of Cessation as Substantial Shareholder - Jaspal Singh Narulla

IX Biopharma

2022-07-06
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notice of Cessation as Substantial Shareholder - Jaspal Singh Narulla

IX Biopharma

2022-02-11
Request for Lifting of Trading Halt::Request for Lifting of Trading Halt

IX Biopharma

2022-02-11
General Announcement::Request for Lifting of Trading Halt - Sponsor's Statement

IX Biopharma

2022-02-11
Request for Lifting of Trading Halt::Request for Lifting Of Trading Halt

IX Biopharma

2022-02-11
Request for Trading Halt::Request for Trading Halt

IX Biopharma

2022-02-11
General Announcement::Press Release: iX Biopharma Records 1H22 Net Profit of S$3.66M

IX Biopharma

2022-02-11
Financial Statements and Related Announcement::Half Yearly Results

IX Biopharma

2022-02-04
General Announcement::Change of Secretaries

IX Biopharma

2022-01-28
General Announcement::APPOINTMENT OF NON-EXECUTIVE INDEPENDENT DIRECTOR & CHANGE IN COMPOSITION OF BOARD & ITS COMMITTEES

IX Biopharma

2022-01-28
Change - Announcement of Appointment::APPOINTMENT OF NON-EXECUTIVE INDEPENDENT DIRECTOR

IX Biopharma

2022-01-20
General Announcement::Phillip Securities Presentation - January 2022

IX Biopharma

2022-01-09
General Announcement::WAFERMINE LICENSING TRANSACTION - RECEIPT OF UPFRONT PAYMENT

IX Biopharma

2021-12-06
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Albert Ho Shing Tung

IX Biopharma

2021-12-06
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Eddy Lee Yip Hang

IX Biopharma

2021-11-29
Annual Reports and Related Documents::

IX Biopharma

2021-11-24
General Announcement::REQUEST FOR LIFTING OF TRADING HALT - SPONSOR'S STATEMENT

IX Biopharma

2021-11-24
Request for Lifting of Trading Halt::Request for Lifting of Trading Halt

IX Biopharma

2021-11-24
General Announcement::EXCLUSIVE LICENSE AGREEMENT FOR WAFERMINE AND OTHER SUBLINGUAL KETAMINE WAFER PRODUCTS

IX Biopharma

2021-11-23
Request for Trading Halt::Request for Trading Halt

IX Biopharma

2021-11-22
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Albert Ho Shing Tung

IX Biopharma

2021-11-22
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Eddy Lee Yip Hang

IX Biopharma

2021-11-21
Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN

IX Biopharma

2021-10-27
General Announcement::CHANGES IN THE COMPOSITION OF THE BOARD AND BOARD COMMITTEES

IX Biopharma

2021-10-26
General Announcement::Minutes of Annual General Meeting held on 15 October 2021

IX Biopharma

2021-10-25
General Announcement::iX Biopharma Expands Nutraceuticals Portfolio With Innovative Anti-Aging Sublingual NAD+ Product

IX Biopharma

2021-10-15
REPL::Annual General Meeting::Voluntary

IX Biopharma

2021-10-14
General Announcement::QUESTIONS AND ANSWERS PROVIDED AHEAD OF THE UPCOMING AGM TO BE HELD ON 15 OCTOBER 2021

IX Biopharma

2021-09-29
Change - Announcement of Cessation::Retirement of Independent Non-Executive Director - Claudia Teo Kwee Yee

IX Biopharma

2021-09-29
General Announcement::iX Biopharma Signs Wafesil Licensing Agreement with China Resources Pharmaceutical Commercial Group

IX Biopharma

2021-09-28
Annual Reports and Related Documents::

IX Biopharma

2021-09-28
Annual General Meeting::Voluntary

IX Biopharma

2021-08-23
Financial Statements and Related Announcement::Full Yearly Results

IX Biopharma

2021-07-27
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Low Weng Keong

IX Biopharma

2021-07-27
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Teo Kwee Yee

IX Biopharma

2021-07-27
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Albert Ho Shing Tung

IX Biopharma

2021-07-27
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Eddy Lee Yip Hang

IX Biopharma

2021-07-26
General Announcement::Press Release: iX Biopharma to Export Sublingual Medicinal Cannabis Wafer to New Zealand

IX Biopharma

2021-07-25
General Announcement::RESULTS OF THE RIGHTS ISSUE AND LISTING AND QUOTATION OF THE RIGHTS SHARES

IX Biopharma

2021-07-16
Employee Stock Option/ Share Scheme::GRANT OF SHARE OPTION PURSUANT TO iX EMPLOYEE SHARE OPTION SCHEME

IX Biopharma

2021-07-11
General Announcement::PROPOSED SPIN-OFF AND LISTING OF PHARMACEUTICAL AND MEDICINAL CANNABIS BUSINESS ON THE HKEX

IX Biopharma

2021-07-06
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Teo Kwee Yee

IX Biopharma

2021-07-06
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Low Weng Keong

IX Biopharma

2021-07-06
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Albert Ho Shing Tung

© 2026 Dividends.sg